Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial
Titel:
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial
Auteur:
Olawaiye, Alexander B Gladieff, Laurence O'Malley, David M Kim, Jae-Weon Garbaos, Gabriel Salutari, Vanda Gilbert, Lucy Mileshkin, Linda Devaux, Alix Hopp, Elizabeth Lee, Yong Jae Oaknin, Ana Scaranti, Mariana Kim, Byoung-Gie Colombo, Nicoletta McCollum, Michael E Diakos, Connie Clamp, Andrew Leiser, Aliza L Balázs, Boglárka Monk, Bradley J Scandurra, Giuseppa McClung, Emily Kaczmarek, Emilie Slomovitz, Brian De La Cueva, Helena de Carvalho Calabrich, Aknar Freire Cassani, Chiara You, Benoit Van Gorp, Toon Churruca, Cristina Caruso, Giuseppe Nicum, Shibani Bagaméri, Andrea Artioli, Grazia Bodnar, Lubomir Kang, Sokbom Vergote, Ignace Kesner-Hays, Amanda Pashova, Hristina I Pai, Sachin G Tudor, Iulia Cristina Jubb, Adrian M Lorusso, Domenica